Literature DB >> 1460001

Cytotoxicity of momordin-folate conjugates in cultured human cells.

C P Leamon1, P S Low.   

Abstract

We have shown previously that macromolecules can be nondestructively delivered into cultured cells via folate receptor-mediated endocytosis if the macromolecules are conjugated to folic acid prior to addition to receptor-bearing cells (Leamon, C.P., and Low, P. S. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 5572-5576). Although an intracellular destination of the folate-linked proteins could be easily documented, the spatial resolution of the earlier data was insufficient to evaluate whether any endocytosed material was delivered into the cytosol. To resolve this issue, a folate-toxin conjugate was constructed using the impermeable ribosome-inactivating protein, momordin. Diminution of [3H]leucine incorporation into newly synthesized protein was then employed as a quantitative measure of the entry of the toxin into the cytosol. In studies with both HeLa and KB cells, cellular protein synthesis was found to be inhibited in a time- and concentration-dependent manner by the momordin-folate conjugate, but not by the underivatized toxin. IC50 values centered around 10(-9) M for the folate-linked samples. These observations provide direct evidence that folate conjugates not only reach the cytosol, but do so in a functionally active form.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1460001

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  In vitro and in vivo targeting of different folate receptor-positive cancer cell lines with a novel 99mTc-radiofolate tracer.

Authors:  Cristina Müller; P August Schubiger; Roger Schibli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-24       Impact factor: 9.236

2.  Expression levels of functional folate receptors alpha and beta are related to the number of N-glycosylated sites.

Authors:  F Shen; H Wang; X Zheng; M Ratnam
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

3.  Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy.

Authors:  Santimukul Santra; Charalambos Kaittanis; Oscar J Santiesteban; J Manuel Perez
Journal:  J Am Chem Soc       Date:  2011-09-27       Impact factor: 15.419

4.  Transduction of folate receptor cDNA into cervical carcinoma cells using recombinant adeno-associated virions delays cell proliferation in vitro and in vivo.

Authors:  X L Sun; B R Murphy; Q J Li; S Gullapalli; J Mackins; H N Jayaram; A Srivastava; A C Antony
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

5.  Application of a water-soluble pyridyl disulfide amine linker for use in Cu-free click bioconjugation.

Authors:  Joshua D Thomas; Terrence R Burke
Journal:  Tetrahedron Lett       Date:  2011-08-17       Impact factor: 2.415

6.  A role for the proton-coupled folate transporter (PCFT-SLC46A1) in folate receptor-mediated endocytosis.

Authors:  Rongbao Zhao; Sang Hee Min; Yanhua Wang; Estela Campanella; Philip S Low; I David Goldman
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

7.  Folate-mediated targeting of antisense oligodeoxynucleotides to ovarian cancer cells.

Authors:  S Li; H M Deshmukh; L Huang
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

Review 8.  Environmentally responsive peptides as anticancer drug carriers.

Authors:  Suhaas Aluri; Siti M Janib; J Andrew Mackay
Journal:  Adv Drug Deliv Rev       Date:  2009-07-20       Impact factor: 15.470

9.  Folate receptor-mediated targeted polymeric gadolinium complexes for magnetic resonance imaging in pulmonary tumor xenografts.

Authors:  Zheng Yuan; Wen-Tao Li; Xiao-Dan Ye; Shi-Yuan Liu; Xiang-Sheng Xiao
Journal:  Exp Ther Med       Date:  2012-03-05       Impact factor: 2.447

10.  Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells.

Authors:  C P Leamon; P S Low
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.